Agenus

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.

About AGEN

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. 

CEO
Garo H. Armen
CEOGaro H. Armen
Employees
441
Employees441
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
1994
Founded1994
Employees
441
Employees441

AGEN Key Statistics

Market cap
583.32M
Market cap583.32M
Price-Earnings ratio
18.11
Price-Earnings ratio18.11
Dividend yield
Dividend yield
Average volume
4.43M
Average volume4.43M
High today
$2.18
High today$2.18
Low today
$2.05
Low today$2.05
Open price
$2.14
Open price$2.14
Volume
1.97M
Volume1.97M
52 Week high
$5.86
52 Week high$5.86
52 Week low
$1.25
52 Week low$1.25

AGEN Earnings

-$0.37
-$0.02
$0.34
$0.69
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.